High Court Rejects Sanofi Inequitable Conduct Appeal

The U.S. Supreme Court has declined to hear an appeal brought by the subsidiaries of Sanofi-Aventis over lower court findings that patents for Lovenox were invalid because of inequitable conduct, leaving...

Already a subscriber? Click here to view full article